Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial

Article

Abstract: The value of quantitative immunoprecipitation mass spectrometry (QIP-MS) to identify the M-protein i

Palabras claves:

Autores:

Adrián Alegre, Albert Oriol, Álvarez M.A., Ana Isabel Teruel, Ana Pilar González-Rodríguez, Aránzazu García-Mateo, Bruno Paiva, Cristina Agulló, de la Rubia J., Enrique M. Ocio, Felipe de Arriba, Fernando Escalante, Gutiérrez N.C., Irene Aires, Javier López-Jiménez, Jesus San Miguel, Joan Bargay, Joan Bladé, Joaquín Martínez-López, José Juan Pérez, Juan José Lahuerta, Laura Rosiñol, Luis Palomera, María Belén Iñigo, María José Calasanz, María Teresa Cedena, María V. Mateos, Marta Reinoso, Marta S. González, Miguel T. Hernández, Noemí Puig, Paula Rodríguez-Otero, Rafael Ríos-Tamayo, Ramón García-Sanz, Sergio Castro, Terry Contreras, Verónica González-Calle

Fuentes:

scopus